Literature DB >> 17591779

PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.

Yun-Ju Lai1, Weei-Chin Lin, Fang-Tsyr Lin.   

Abstract

The LIM domain-containing TRIP6 (Thyroid Hormone Receptor-interacting Protein 6) is a focal adhesion molecule known to regulate lysophosphatidic acid (LPA)-induced cell migration through interaction with the LPA2 receptor. LPA stimulation targets TRIP6 to the focal adhesion complexes and promotes c-Src-dependent phosphorylation of TRIP6 at Tyr-55, which creates a docking site for the Crk Src homology 2 domain, thereby promoting LPA-induced morphological changes and cell migration. Here we further demonstrate that a switch from c-Src-mediated phosphorylation to PTPL1/Fas-associated phosphatase-1-dependent dephosphorylation serves as an inhibitory feedback control mechanism of TRIP6 function in LPA-induced cell migration. PTPL1 dephosphorylates phosphotyrosine 55 of TRIP6 in vitro and inhibits LPA-induced tyrosine phosphorylation of TRIP6 in cells. This negative regulation requires a direct protein-protein interaction between these two molecules and the phosphatase activity of PTPL1. In contrast to c-Src, PTPL1 prevents TRIP6 turnover at the sites of adhesions. As a result, LPA-induced association of TRIP6 with Crk and the function of TRIP6 to promote LPA-induced morphological changes and cell migration are inhibited by PTPL1. Together, these results reveal a novel mechanism by which PTPL1 phosphatase plays a counteracting role in regulating TRIP6 function in LPA-induced cell migration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591779      PMCID: PMC3923842          DOI: 10.1074/jbc.M701499200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Adhesion assembly, disassembly and turnover in migrating cells -- over and over and over again.

Authors:  Donna J Webb; J Thomas Parsons; Alan F Horwitz
Journal:  Nat Cell Biol       Date:  2002-04       Impact factor: 28.824

2.  Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST.

Authors:  A J Garton; N K Tonks
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

3.  GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Authors:  Chang-Wook Lee; Richard Rivera; Shannon Gardell; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

4.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.

Authors:  J W Lee; H S Choi; J Gyuris; R Brent; D D Moore
Journal:  Mol Endocrinol       Date:  1995-02

5.  Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility.

Authors:  S Mañes; E Mira; C Gómez-Mouton; Z J Zhao; R A Lacalle; C Martínez-A
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 6.  Src kinase regulation by phosphorylation and dephosphorylation.

Authors:  Robert Roskoski
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

Review 7.  Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear.

Authors:  Yuan Wang; Thomas D Gilmore
Journal:  Biochim Biophys Acta       Date:  2003-02-17

8.  Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.

Authors:  K Bandoh; J Aoki; H Hosono; S Kobayashi; T Kobayashi; K Murakami-Murofushi; M Tsujimoto; H Arai; K Inoue
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

9.  c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.

Authors:  Yun-Ju Lai; Chen-Shan Chen; Weei-Chin Lin; Fang-Tsyr Lin
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

10.  Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.

Authors:  Kyoko Noguchi; Satoshi Ishii; Takao Shimizu
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

View more
  21 in total

1.  Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells.

Authors:  Carolina Castilla; M Luz Flores; José M Conde; Rafael Medina; Francisco J Torrubia; Miguel A Japón; Carmen Sáez
Journal:  Clin Exp Metastasis       Date:  2012-01-25       Impact factor: 5.150

2.  PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

Authors:  Murielle Glondu-Lassis; Mathilde Dromard; Magali Lacroix-Triki; Philippe Nirdé; Carole Puech; Dora Knani; Dany Chalbos; Gilles Freiss
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.

Authors:  Yun-Ju Lai; Victor T G Lin; Ying Zheng; Etty N Benveniste; Fang-Tsyr Lin
Journal:  Mol Cell Biol       Date:  2010-09-27       Impact factor: 4.272

Review 4.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

Review 5.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

Review 6.  TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity.

Authors:  Victor T G Lin; Fang-Tsyr Lin
Journal:  Cell Signal       Date:  2011-06-13       Impact factor: 4.315

Review 7.  [Research progress on the biological regulatory function of lysophosphatidic acid in bone tissue cells].

Authors:  Xiang-Nan Wu; Yuan-Yuan Ma; Zhi-Chao Hao; Hang Wang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-06-01

8.  Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions.

Authors:  Gyöngyi N Kiss; James I Fells; Renuka Gupte; Sue-Chin Lee; Jianxiong Liu; Nóra Nusser; Keng G Lim; Ramesh M Ray; Fang-Tsyr Lin; Abby L Parrill; Balázs Sümegi; Duane D Miller; Gabor Tigyi
Journal:  Mol Pharmacol       Date:  2012-09-11       Impact factor: 4.436

9.  Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency.

Authors:  Jessica L Crowley; Tara C Smith; Zhiyou Fang; Norio Takizawa; Elizabeth J Luna
Journal:  Mol Biol Cell       Date:  2008-12-24       Impact factor: 4.138

Review 10.  Regulation of the LPA2 receptor signaling through the carboxyl-terminal tail-mediated protein-protein interactions.

Authors:  Fang-Tsyr Lin; Yun-Ju Lai
Journal:  Biochim Biophys Acta       Date:  2008-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.